PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $267,000 | +66.9% | 59,480 | +81.0% | 0.02% | +23.1% |
Q3 2021 | $160,000 | -17.1% | 32,867 | +6.8% | 0.01% | -35.0% |
Q4 2020 | $193,000 | -22.2% | 30,781 | +26.5% | 0.02% | +17.6% |
Q2 2018 | $248,000 | -53.1% | 24,336 | -40.2% | 0.02% | -54.1% |
Q1 2018 | $529,000 | – | 40,703 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
CM Management, LLC | 200,000 | $972,000 | 0.72% |
GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |